Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Parsippany, New Jersey
- Most recent report
- 10-Q, filed Aug 13, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1410098
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer
Financials 8 of 69
News 8 of 255
- 8-K Quarterly results Aug 13, 2026
- 8-K Other events Aug 7, 2026
- 8-K Other events Jul 2, 2026
- 8-K Current report on a material event Jul 1, 2026
- 8-K Shareholder vote results Jun 24, 2026
- 8-K Current report on a material event Jun 8, 2026
- 8-K Quarterly results May 14, 2026
- 8-K Current report on a material event Apr 27, 2026
Prospectuses and Registrations 8 of 65
- S-8 POS Post-effective amendment to an employee plan registration Jun 25, 2026
- S-8 Registration statement for an employee plan Nov 13, 2025
- S-3ASR Automatic shelf registration Oct 7, 2025
- S-3ASR Automatic shelf registration Oct 6, 2025
- S-3 Shelf registration statement Sep 30, 2025
- 424B5 Prospectus supplement for an offering Jun 30, 2025
- 424B5 Prospectus supplement for an offering Jun 26, 2025
- S-3 Shelf registration statement May 9, 2024
Proxies 8 of 46
- DEFA14A Extra proxy material Apr 29, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2026
- PRE 14A Preliminary proxy statement Apr 17, 2026
- DEF 14A Proxy statement for a shareholder vote Oct 24, 2025
- PRE 14A Preliminary proxy statement Sep 15, 2025
- DEFA14A Extra proxy material Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Oct 8, 2024
Ownership 8 of 515
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jun 12, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jun 12, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 15, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Mar 26, 2026
- 4 Insider reported a trade Feb 6, 2026
- 4 Insider reported a trade Feb 6, 2026
- 4 Insider reported a trade Feb 6, 2026
- 4 Insider reported a trade Jan 27, 2026
Other 8 of 50
- ARS Annual report sent to shareholders Apr 29, 2026
- PRER14A Oct 14, 2025
- RW Oct 7, 2025
- RW Oct 6, 2025
- ARS Annual report sent to shareholders Apr 28, 2025
- EFFECT Notice that a registration became effective May 22, 2024
- CORRESP Reply to SEC staff May 20, 2024
- UPLOAD Comment letter from SEC staff May 15, 2024
Everything here comes from CorMedix Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.